The Czech Republic's only dedicated comprehensive cancer centre, OECI-accredited and known for its RECAMO translational research centre.
The Masaryk Memorial Cancer Institute opened in 1935 as the 'House of Comfort' with the support of President Tomáš Garrigue Masaryk and is the only specialised comprehensive cancer centre in the Czech Republic, accredited by the OECI. Its Regional Centre for Applied Molecular Oncology (RECAMO), founded by Bořivoj Vojtěšek, develops antibodies and biomarkers for p53 and other targets in collaboration with Edinburgh and international groups, and the institute runs the Czech phase 1 unit for academic trials under Regina Demlová. Clinical services span surgical oncology, radiotherapy with brachytherapy and stereotactic techniques, medical oncology, nuclear medicine and a large prevention and screening centre, and the institute contributes to the national cancer registry and screening programmes.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-16.
Matched to Masaryk Memorial Cancer Institute, including child institutions. 155 works · 1,946 citations · 83% open access · 16% clinical trials · 3% reviews.
Medical oncologist responsible for clinical care at Masaryk Memorial Cancer Institute, with expertise in gastrointestinal oncology.
Medical oncologist who leads the Masaryk Memorial Cancer Institute in Brno, the Czech Republic's largest dedicated cancer centre.
Radiation oncologist directing science and research at Masaryk Memorial Cancer Institute, with a research focus on brain tumours and brain metastases.
Shares Tomáš Kazda, Marek Svoboda, IMRT / IGRT (modern external beam).
Shares Brachytherapy, Organisation of European Cancer Institutes, Comprehensive genomic profiling, IMRT / IGRT (modern external beam).
Shares Institute of Biostatistics and Analyses, Masaryk University, Organisation of European Cancer Institutes.
Shares Motol University Hospital, Organisation of European Cancer Institutes.
Shares Brachytherapy, Organisation of European Cancer Institutes, IMRT / IGRT (modern external beam), Melanoma.
Shares Brachytherapy, Comprehensive genomic profiling, IMRT / IGRT (modern external beam), HR-positive / HER2-negative breast cancer.
Shares Brachytherapy, Organisation of European Cancer Institutes, HR-positive / HER2-negative breast cancer, Prostate cancer.
Shares Brachytherapy, Comprehensive genomic profiling, IMRT / IGRT (modern external beam), HR-positive / HER2-negative breast cancer.